Rezzayo

Active Ingredient(s): Rezafungin Acetate
FDA Approved: * March 22, 2023
Pharm Company: * CIDARA THERAPS
Category: Antifungal
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Rezzayo 200 mg Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 70842-240
Labeler:
Melinta Therapeutics, LLC